Oscar Health Inc (NYSE:OSCR)

$ 17.99 -0.44 (-2.39%) Market Cap: 4.45 Bil Enterprise Value: 3.65 Bil PE Ratio: 0 PB Ratio: 3.83 GF Score: 60/100

Q3 2024 Oscar Health Inc Earnings Call Transcript
Nov 07, 2024

$13.64 (-12.28%)

Earnings
Q2 2024 Oscar Health Inc Earnings Call Transcript
Aug 07, 2024

$16.7 (-3.08%)

Earnings
Q1 2024 Oscar Health Inc Earnings Call Transcript
May 07, 2024

$19.77 (+4.22%)

Earnings
Q4 2023 Oscar Health Inc Earnings Call Transcript
Feb 07, 2024

$13.41 (-1.32%)

Earnings
Oscar Health Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Q3 2023 Oscar Health Inc Earnings Call Transcript
Nov 07, 2023

$6.62 (+15.94%)

Earnings
Oscar Health Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 11, 2023
Q2 2023 Oscar Health Inc Earnings Call Transcript
Aug 08, 2023

$7.13 (-3.13%)

Earnings
Oscar Health Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023
Q1 2023 Oscar Health Inc Earnings Call Transcript
May 09, 2023

$7.14 (-5.05%)

Earnings
Oscar Health Inc Appointment of CEO - Corporate Call Transcript
Mar 28, 2023
Q4 2022 Oscar Health Inc Earnings Call Transcript
Feb 09, 2023

$3.8 (-7.09%)

Earnings
Oscar Health Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Q3 2022 Oscar Health Inc Earnings Call Transcript
Nov 08, 2022

$3.07 (-0.65%)

Earnings
Oscar Health Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022
Q2 2022 Oscar Health Inc Earnings Call Transcript
Aug 11, 2022

$6.52 (+0.62%)

Earnings
Oscar Health Inc at Bank of America Healthcare Conference Transcript
May 12, 2022
Q1 2022 Oscar Health Inc Earnings Call Transcript
May 10, 2022

$6.14 (-5.83%)

Earnings
Oscar Health Inc To Host Investor Day (Virtual) Transcript
Mar 25, 2022
Q4 2021 Oscar Health Inc Earnings Call Transcript
Feb 10, 2022

$6.42 (-1.83%)

Earnings
Oscar Health Inc Analyst Call Transcript
Jan 27, 2022
Q3 2021 Oscar Health Inc Earnings Call Transcript
Nov 10, 2021

$16.52 (+1.60%)

Earnings
Oscar Health Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Oscar Health Inc Earnings Call Transcript
Aug 12, 2021

$14.66 (-1.21%)

Earnings
Oscar Health Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
Q1 2021 Oscar Health Inc Earnings Call Transcript
May 13, 2021

$20.51 (-7.36%)

Earnings

Oscar Health Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 12:00PM GMT

Release Date Price: $6.57 (+1.86%)

Transcript

Hua Ha

Morgan Stanley, Research Division - Equity Analyst

All right. Welcome, everyone. My name is Michael Ha, I'm the managed care and health care services analyst at Morgan Stanley. Our next session or our first session actually is with Oscar Health, a technology-enabled managed care company with plan offerings in the individual exchange marketplace and small group as well as selling its technology to help systems providers and other health plans. I'm pleased to have with us today, Chief Executive Officer, Mark Bertolini. So with that said, thanks again. And Mark, I'd like to turn it over to you for some introductory remarks.

Mark Thomas Bertolini

Oscar Health, Inc. - CEO & Director

Sure. I'd start off by saying our fundamentals are strong. We're executing well. 2024 pricing and growth environment looks solid for us and the tech platform is really delivering. On part of our, what has been noted, moderate pricing versus the market is a large of our ability to now execute against the tech platform in ways that reduce our costs. and allow us to bring more

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.